Bailin He
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Depletion of CD8+ CART cells leads to superior anti-tumor efficacy of pure CD4+ CART cells against acute leukemias.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 15, 2025
Depletion of CD8+ CAR T-cells leads to superior anti-tumor efficacy of pure CD4+ CAR T-cells against Acute Leukemias.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 15, 2025
Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial.
Journal: Journal of translational medicine
Published: March 09, 2025
Paediatric-inspired regimen reduces central nervous system relapse in adult acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: January 21, 2025
Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways.
Journal: Experimental hematology & oncology
Published: December 01, 2024
Tucidinostat plus pediatric-inspired chemotherapy for newly diagnosed adult ETP-ALL/LBL: a single-arm, phase 2 trial.
Journal: Journal of hematology & oncology
Published: September 12, 2024
Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.
Journal: Experimental hematology & oncology
Published: September 12, 2024
Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.
Journal: Experimental hematology & oncology
Published: June 17, 2024
Author Correction: A crucial role of the PD-1H coinhibitory receptor in suppressing experimental asthma.
Journal: Cellular & molecular immunology
Published: May 22, 2023
Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies.
Journal: Frontiers in immunology
Published: December 23, 2022
PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma.
Journal: Frontiers in molecular biosciences
Published: September 15, 2021
Last Updated: 09/26/2026